Results 71 to 75 of about 247 (75)
Some of the next articles are maybe not open access.

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Leukemia, 2018
S. Modvig   +24 more
semanticscholar   +1 more source

Identification of HLA-A, HLA-B and HLA-C triple homozygous and double homozygous donors: a path towards synthetic superdonor Advanced Therapeutic Medicinal Products

medRxiv
D. Naumovas   +13 more
semanticscholar   +1 more source

POSTER: AML-535 Gilteritinib in Combination With Venetoclax, Low-Dose Cytarabine, and Actinomycin D As Salvage Therapy for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia (FLT3m R/R AML): A Single-Center Retrospective Study

Clinical Lymphoma, Myeloma & Leukemia
Milda Mikalonytė   +15 more
semanticscholar   +1 more source

Reliability of the Butterfly Test - A Clinical Assessment to Quantify Movement Control of the Cervical Spine

Archives of Physical Medicine and Rehabilitation
Z. M. Rošker   +4 more
semanticscholar   +1 more source

Venetoclax-Based Preconditioning Followed by Immediate Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) or High-Risk Myelodysplastic Syndromes (HR-MDS)

Clinical Lymphoma, Myeloma & Leukemia
L. Kevličius   +21 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy